TPIDB > 臨床試驗主持人
臨床試驗主持人
發表文獻
23筆
21
Wang, T. D., Lee, Y. H., Chang, S. S., Tung, Y. C., Yeh, C. F., Lin, Y. H., Pan, C. T., Hsu, C. Y., Huang, C. Y., Wu, C. K., Sung, P. H., Chiang, L. T., Wang, Y. C., Tsai, W. C., Lin, T. T., Lin, C. P., Chen, W. J., & Hwang, J. J. (2019). 2019 Consensus Statement of the Taiwan Hypertension Society and the Taiwan Society of Cardiology on Renal Denervation for the Management of Arterial Hypertension. Acta Cardiologica Sinica, 35(3), 199-230. https://doi.org/10.6515/acs.201905_35(3).20190415a
22
Wu, C. K., Cheng, J. F., Huang, C. Y., Chen, Z. W., Chen, S. Y., & Lin, L. Y. (2021). Iloprost and exercise haemodynamics in heart failure with preserved ejection fraction-the ILO-HOPE randomised controlled trial. British Journal of Clinical Pharmacology, 87(3), 1165-1174. https://doi.org/10.1111/bcp.14484
23
Wu, C. K., Lee, J. K., Hsu, J. C., Su, M. Y. M., Wu, Y. F., Lin, T. T., Lan, C. W., Hwang, J. J., & Lin, L. Y. (2020). Myocardial adipose deposition and the development of heart failure with preserved ejection fraction. European Journal of Heart Failure, 22(3), 445-454. https://doi.org/10.1002/ejhf.1617